CD55 anticorps
Aperçu rapide pour CD55 anticorps (ABIN499054)
Antigène
Voir toutes CD55 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Specificité
- This antibody detects endogenous levels of CD55 protein. (region surrounding Lys142)
-
Réactivité croisée (Details)
- Species reactivity (tested):Human.
-
Purification
- Affinity Chromatography using epitope-specific immunogen
-
-
-
-
Indications d'application
-
Western Blot: 1/500 - 1/1000.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Phosphate buffered saline (PBS), pH ~7.2, 0.05 % Sodium Azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid repeated freezing and thawing.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Autre désignation
- CD55 / DAF
-
Sujet
- Avoidance by host tissues of attack by autologous complement proteins is dependent in part on the activities of membrane regulatory factors. One molecule involved in this control is a 70 kD glycoprotein termed decay-accelerating factor (DAF), or CD55. Interruption by CD55 of the complement sequence at an early step in activation effectively halts progression of the cascade and prevents consequent cell injury. In man, CD55 is expressed on the plasma membrane of all cell types that are in intimate contact with plasma complement proteins.Synonyms: Complement decay-accelerating factor
-
Poids moléculaire
- approx. 41 kDa
-
ID gène
- 1604
-
NCBI Accession
- NP_000565
-
UniProt
- P08174
-
Pathways
- Système du Complément, Regulation of Leukocyte Mediated Immunity
Antigène
-